Valuation: Camurus AB

Market Cap 35.91B 3.75B 3.26B 3.05B 2.8B 5.27B 358B 5.36B 14.07B 178B 14.1B 13.79B 589B P/E 2026 *
37.5x
P/E 2027 * 24.3x
Enterprise Value 31.4B 3.28B 2.85B 2.66B 2.44B 4.61B 313B 4.69B 12.3B 156B 12.33B 12.05B 514B EV / Sales 2026 *
11x
EV / Sales 2027 * 8.03x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day-0.37%
1 week-3.37%
Current month-2.43%
1 month+3.97%
3 months+10.05%
6 months-10.21%
Current year-2.19%
1 week 598
Extreme 598
638
1 month 525.5
Extreme 525.5
645
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 279.2
Extreme 279.2
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap.
2/27/26 A Sell

Chief Executive Officer

55,550 0.0928%
2/27/26 A Sell

Chief Executive Officer

1,500 0.0025%
2/27/26 A Sell

Chief Executive Officer

9,950 0.0166%
Change 5-day change 1-year change 3-year change Capi.($)
-0.46%-3.37%-10.74%+105.35% 3.75B
-2.39%-6.36%+47.10%+149.66% 1T
-0.76%-4.34%+52.04%+49.09% 613B
-2.33%-4.60%+25.55%+64.44% 433B
+0.17%-3.34%+39.45%+34.16% 350B
+0.19%-4.60%+31.53%+39.67% 292B
+1.82%-9.60%+5.05%+7.22% 239B
+1.99%-8.23%-1.66%-42.01% 206B
-1.63%+0.69%+27.62%+64.23% 204B
+0.72%+0.48%+15.88%+73.64% 163B
Average +0.11%-3.70%+23.18%+54.54% 350.42B
Weighted average by Cap. +0.09%-4.34%+34.85%+71.28%

Financials

2026 *2027 *
Net sales 2.86B 299M 259M 242M 222M 419M 28.46B 427M 1.12B 14.19B 1.12B 1.1B 46.81B 3.75B 392M 340M 318M 292M 550M 37.34B 560M 1.47B 18.62B 1.47B 1.44B 61.41B
Net income 949M 99.2M 86.21M 80.49M 73.89M 139M 9.46B 142M 372M 4.72B 373M 364M 15.55B 1.45B 152M 132M 123M 113M 213M 14.47B 217M 569M 7.21B 570M 558M 23.8B
Net Debt -4.52B -472M -410M -383M -352M -663M -45B -675M -1.77B -22.44B -1.77B -1.73B -74.02B -5.81B -607M -528M -492M -452M -852M -57.85B -867M -2.27B -28.85B -2.28B -2.23B -95.16B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
04/08/26 SEK 602.50 -0.17% 10,001
03/08/26 SEK 603.50 -2.27% 78,764
31/07/26 SEK 617.50 -0.56% 203,437
30/07/26 SEK 621.00 -0.72% 49,654
29/07/26 SEK 625.50 +0.32% 48,812
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
603.50SEK
Average target price
793.00SEK
Spread / Average Target
+31.40%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock